GrowBLOX Sciences, Inc. (GBLX) Plans to Utilize Th
Post# of 118
Posted On: 07/01/2015 5:27:39 PM
GrowBLOX Sciences, Inc. (GBLX) Plans to Utilize Three Phase Retail Distribution Solutions to Promote Industry Growth
Through the commercialization of its proprietary cannabis cultivation technology, GrowBLOX Sciences, Inc. (OTCQB: GBLX) is building a formidable presence in the burgeoning medicinal cannabis industry. In order to capitalize on this position, the company plans to utilize a specialized three phase retail distribution solution that will allow for comprehensive coverage of the country’s legalized medicinal cannabis markets.
Phase one of GrowBLOX’s projected retail channel solutions is The Apothecary. This unique retail environment combines a simple, clean and clinical design with cutting-edge biometrics and patient verification to ensure a pleasant and safe customer experience. When visiting The Apothecary, patients will have access to highly trained and certified patient-care professionals, who will help determine medical needs and identify therapeutic solutions. Since doctors have limited training in the benefits of cannabinoid therapy products, these professionals are essential to the company’s patient education efforts. For an inside view of The Apothecary, visit https://vimeo.com/129493221.
In order to expand its retail distribution network and bypassing the costs of traditional brick and mortar locations, GrowBLOX Sciences will also offer a collection of Micro-Apothecary self-service vending kiosks, which will serve as phase two of the company’s retail channel solutions. These machines will provide validated patients with a quick and easy way to obtain the company’s products. Since the Micro-Apothecary can be installed in any existing retail location or traditional pharmacy permitted to sell medical cannabis products or distribute clinical trial medication doses. This prudent approach offers GBLX a cost-effective method of exponentially expanding its distribution network in the years to come.
The final phase of the company’s projected retail network is its innovative mobile app. Set to be released in the second half of 2015, this powerful tool will allow patients to generate profiles, track symptoms, browse local inventory options and order products for pickup or delivery through the use of a mobile device. This mobile app will be essential for tracking valuable patient data and streamline distribution efforts beyond the bounds of its physical locations in order to maximize potential growth moving forward.
With a full network of projected retail channel solutions in place, GBLX is in a solid position to promote strong returns in the future. In the coming months, look for the company to continue building upon its recent commercial progress in an effort to maximize market share within the expanding medicinal cannabis industry.
For more information, visit www.gbsciences.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
Through the commercialization of its proprietary cannabis cultivation technology, GrowBLOX Sciences, Inc. (OTCQB: GBLX) is building a formidable presence in the burgeoning medicinal cannabis industry. In order to capitalize on this position, the company plans to utilize a specialized three phase retail distribution solution that will allow for comprehensive coverage of the country’s legalized medicinal cannabis markets.
Phase one of GrowBLOX’s projected retail channel solutions is The Apothecary. This unique retail environment combines a simple, clean and clinical design with cutting-edge biometrics and patient verification to ensure a pleasant and safe customer experience. When visiting The Apothecary, patients will have access to highly trained and certified patient-care professionals, who will help determine medical needs and identify therapeutic solutions. Since doctors have limited training in the benefits of cannabinoid therapy products, these professionals are essential to the company’s patient education efforts. For an inside view of The Apothecary, visit https://vimeo.com/129493221.
In order to expand its retail distribution network and bypassing the costs of traditional brick and mortar locations, GrowBLOX Sciences will also offer a collection of Micro-Apothecary self-service vending kiosks, which will serve as phase two of the company’s retail channel solutions. These machines will provide validated patients with a quick and easy way to obtain the company’s products. Since the Micro-Apothecary can be installed in any existing retail location or traditional pharmacy permitted to sell medical cannabis products or distribute clinical trial medication doses. This prudent approach offers GBLX a cost-effective method of exponentially expanding its distribution network in the years to come.
The final phase of the company’s projected retail network is its innovative mobile app. Set to be released in the second half of 2015, this powerful tool will allow patients to generate profiles, track symptoms, browse local inventory options and order products for pickup or delivery through the use of a mobile device. This mobile app will be essential for tracking valuable patient data and streamline distribution efforts beyond the bounds of its physical locations in order to maximize potential growth moving forward.
With a full network of projected retail channel solutions in place, GBLX is in a solid position to promote strong returns in the future. In the coming months, look for the company to continue building upon its recent commercial progress in an effort to maximize market share within the expanding medicinal cannabis industry.
For more information, visit www.gbsciences.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
(0)
(0)